TrialAntiviral therapy2010

Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months.

Paediatric European Network for Treatment of AIDS (PENTA)PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.